Biosimilar sponsors can expect FDA to actively participate in development programs long before a marketing application is filed, in part to help sponsors avoid costly and time-consuming missteps.
Five meeting types are included in the biosimilar user fee program for sponsors to receive advice and have questions answered...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?